Document Detail

Regulation of compounding by the food and drug administration: a tale of 2 circuits.
MedLine Citation:
PMID:  21507854     Owner:  NLM     Status:  In-Data-Review    
Federal regulation of the traditional art of pharmacy practice compounding is an unsettled area of the law and the profession. For many years, the Food and Drug Administration (FDA) was not interested in compounding. Attempts to regulate by FDA and Congress have caused difficulty within the profession, litigation with inconsistent results, and an unsettled state of affairs. There are a number of possible resolutions.
Karl G Williams
Related Documents :
15131564 - First-aid treatment of anaphylaxis to food: focus on epinephrine.
15330554 - Sulfites--a food and drug administration review of recalls and reported adverse events.
844544 - On the location of the tetrapyrrole macrocycle of chlorophyll a in phospholipid vesicle...
3061324 - Aspartame intolerance.
11043684 - Effects of a synthetic facial pheromone on behavior of cats.
15836464 - Obesity: the protein leverage hypothesis.
Publication Detail:
Type:  Journal Article     Date:  2010-05-20
Journal Detail:
Title:  Journal of pharmacy practice     Volume:  23     ISSN:  1531-1937     ISO Abbreviation:  J Pharm Pract     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2011-04-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8900945     Medline TA:  J Pharm Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  502-6     Citation Subset:  IM    
Wegmans School of Pharmacy, St John Fisher College, Rochester, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Arkansas community pharmacists' opinions on providing immunizations.
Next Document:  Does the addition of writing into a pharmacy communication skills course significantly impact studen...